Terence S. Herman

Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in Vivo

Beverly A. Teicher, Terence S. Herman, Sylvia A. Holden et al. · Science · 1990 · 316 citations

Vivo Passage, Medicine, Pharmacology +13

Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.

Beverly A. Teicher, Sylvia A. Holden, Antoine Al-Achi et al. · PubMed · 1990 · 225 citations

Chemoprevention Strategy, Pathology, Fsaiic Murine Fibrosarcoma +19

Involvement of the central nervous system by non-Hodgkin's lymphoma.The southwest oncology group experience

Terence S. Herman, Neel Hammond, Stephen E. Jones et al. · Cancer · 1979 · 219 citations · Full text

Tumor Innervation, Neurological Disorder, Clinical Neurology +16

Superiority of Nabilone over Prochlorperazine as an Antiemetic in Patients Receiving Cancer Chemotherapy

Terence S. Herman, Lawrence H. Einhorn, Stephen E. Jones et al. · New England Journal of Medicine · 1979 · 216 citations

Cannabis Use, Medicinal Chemistry, Drug Intolerance +12

Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma.

William D. Kaplan, M S Jochelson, Terence S. Herman et al. · Journal of Clinical Oncology · 1990 · 163 citations

Oncologic Imaging, Residual Tumor Viability, Pathology +16